Non-Communicable Neurological Disorders and Neuroinflammation

Abstract

Traumatic brain injury, stroke, and neurodegenerative diseases represent a major cause of morbidity and mortality in Africa, as in the rest of the world. Traumatic brain and spinal cord injuries specifically represent a leading cause of disability in the younger population. Stroke and neurodegenerative disorders predominantly target the elderly and are a major concern in Africa, since their rate of increase among the ageing is the fastest in the world. Neuroimmunology is usually not associated with non-communicable neurological disorders, as the role of neuroinflammation is not often considered when evaluating their cause and pathogenesis. However, substantial evidence indicates that neuroinflammation is extremely relevant in determining the consequences of non-communicable neurological disorders, both for its protective abilities as well as for its destructive capacity. We review here current knowledge on the contribution of neuroinflammation and neuroimmunology to the pathogenesis of traumatic injuries, stroke and neurodegenerative diseases, with a particular focus on problems that are already a major issue in Africa, like traumatic brain injury, and on emerging disorders such as dementias.

Salidroside alleviates inflammatory reaction and sciatic nerve injury by inhibiting AKT/NF-κB pathway

“…After PNI, the axons and myelin sheath in the distal segment and the proximal segment degenerated and disintegrated, and Schwann cells (SCs) were damaged, which led to the aggregation of in ammatory cells [3] . Neuroin ammation and neuroimmunology regulation are the main pathogenesis of traumatic injury, stroke and neurodegenerative diseases [4] . The imbalance between pro-in ammatory and antiin ammatory processes may cause changes in the immune activity of related neuroglia cells, hinder nerve recovery and even accelerate neuronal damage [5] .…”

New insights into sodium phenylbutyrate as a pharmacotherapeutic option for neurological disorders

“…These are classified into communicable and noncommunicable NDs. The latter include Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), multiple sclerosis, ischemic/traumatic brain injury, and hepatic encephalopathy (HE) (Ballerini et al., 2022; Deuschl et al., 2020).…”